Enhabit (EHAB) Competitors $7.86 -0.02 (-0.30%) Closing price 03:59 PM EasternExtended Trading$7.86 +0.00 (+0.05%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EHAB vs. AVAH, VRDN, TDOC, AHCO, OMDA, GRAL, PNTG, FTRE, CDNA, and FLGTShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Aveanna Healthcare (AVAH), Viridian Therapeutics (VRDN), Teladoc Health (TDOC), AdaptHealth (AHCO), Omada Health (OMDA), GRAIL (GRAL), The Pennant Group (PNTG), Fortrea (FTRE), CareDx (CDNA), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. Enhabit vs. Its Competitors Aveanna Healthcare Viridian Therapeutics Teladoc Health AdaptHealth Omada Health GRAIL The Pennant Group Fortrea CareDx Fulgent Genetics Aveanna Healthcare (NASDAQ:AVAH) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Do institutionals & insiders have more ownership in AVAH or EHAB? 88.0% of Aveanna Healthcare shares are owned by institutional investors. 7.0% of Aveanna Healthcare shares are owned by insiders. Comparatively, 3.4% of Enhabit shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer AVAH or EHAB? In the previous week, Enhabit had 3 more articles in the media than Aveanna Healthcare. MarketBeat recorded 5 mentions for Enhabit and 2 mentions for Aveanna Healthcare. Enhabit's average media sentiment score of 1.73 beat Aveanna Healthcare's score of 1.21 indicating that Enhabit is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enhabit 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts recommend AVAH or EHAB? Aveanna Healthcare currently has a consensus price target of $7.50, suggesting a potential downside of 8.98%. Enhabit has a consensus price target of $8.67, suggesting a potential upside of 10.32%. Given Enhabit's higher probable upside, analysts plainly believe Enhabit is more favorable than Aveanna Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aveanna Healthcare 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Enhabit 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has stronger earnings & valuation, AVAH or EHAB? Aveanna Healthcare has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAveanna Healthcare$2.02B0.85-$10.93M$0.08103.00Enhabit$1.03B0.38-$156.20M-$2.67-2.94 Is AVAH or EHAB more profitable? Aveanna Healthcare has a net margin of 0.85% compared to Enhabit's net margin of -12.84%. Enhabit's return on equity of 2.72% beat Aveanna Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Aveanna Healthcare0.85% -54.56% 3.17% Enhabit -12.84%2.72%1.25% Which has more volatility and risk, AVAH or EHAB? Aveanna Healthcare has a beta of 2.04, suggesting that its stock price is 104% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.69, suggesting that its stock price is 69% more volatile than the S&P 500. SummaryAveanna Healthcare beats Enhabit on 12 of the 16 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$399.44M$7.75B$5.75B$21.39BDividend YieldN/A2.66%6.66%3.49%P/E Ratio-2.9479.5682.5829.00Price / Sales0.3847.31535.4249.12Price / Cash1.9324.8225.7018.29Price / Book0.6920.2111.195.30Net Income-$156.20M$242.04M$3.28B$997.87M7 Day Performance-1.24%0.26%0.15%-0.01%1 Month Performance20.31%5.53%8.34%6.50%1 Year Performance-6.92%9.03%54.21%11.34% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit3.0123 of 5 stars$7.86-0.3%$8.67+10.3%-6.5%$399.44M$1.03B-2.9410,700News CoveragePositive NewsAVAHAveanna Healthcare3.0044 of 5 stars$7.59+2.2%$7.50-1.2%+41.6%$1.59B$2.02B94.8933,500Positive NewsVRDNViridian Therapeutics1.9793 of 5 stars$18.75+1.0%$37.78+101.5%+25.2%$1.53B$305K-4.8950News CoveragePositive NewsTDOCTeladoc Health3.0712 of 5 stars$7.77+1.2%$9.80+26.2%+7.9%$1.37B$2.54B-6.535,500Positive NewsAHCOAdaptHealth3.8716 of 5 stars$9.26+0.3%$13.40+44.8%-13.6%$1.25B$3.26B17.1610,500Positive NewsOMDAOmada HealthN/A$21.77+3.7%$24.57+12.9%N/A$1.25BN/A0.00849GRALGRAIL1.0316 of 5 stars$33.52+1.8%$31.50-6.0%+132.4%$1.21B$134.29M-2.561,360PNTGThe Pennant Group4.1206 of 5 stars$24.32-1.3%$33.40+37.4%-29.9%$840.02M$695.24M31.167,000News CoveragePositive NewsFTREFortrea3.4829 of 5 stars$8.95+1.0%$12.22+36.6%-57.3%$815.38M$2.70B-0.7915,500Positive NewsGap DownCDNACareDx3.9892 of 5 stars$12.89+1.1%$27.67+114.7%-55.5%$686.24M$333.79M12.64740FLGTFulgent Genetics3.6878 of 5 stars$21.62+0.4%$25.33+17.2%-1.7%$661.79M$283.47M-13.021,313News CoveragePositive News Related Companies and Tools Related Companies AVAH Competitors VRDN Competitors TDOC Competitors AHCO Competitors OMDA Competitors GRAL Competitors PNTG Competitors FTRE Competitors CDNA Competitors FLGT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EHAB) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EHAB Stock Alerts